UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042505
Receipt number R000048516
Scientific Title Investigation of effects of blackcurrant extract on suppression of myopia progression
Date of disclosure of the study information 2020/11/21
Last modified on 2021/11/22 16:33:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of effects of blackcurrant extract on suppression of myopia progression

Acronym

Investigation of effects of blackcurrant extract on suppression of myopia progression

Scientific Title

Investigation of effects of blackcurrant extract on suppression of myopia progression

Scientific Title:Acronym

Investigation of effects of blackcurrant extract on suppression of myopia progression

Region

Japan


Condition

Condition

Japanese healthy children in the ages greater than or equal 9, and less than 12

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of effects of continuous intake of blackcurrant extract for one year on suppression of myopia progression

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Eye axial length

Key secondary outcomes

Naked visual acuity, corrected visual acuity, objective refractive index (other-angle refractive index), intraocular pressure, contrast visual acuity, and questionnaire.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

9 years-old <=

Age-upper limit

12 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Healthy Japanese children in the ages greater than or equals to 8 and less than 12.(Gender ratio is intended to be 50/50)
(2) A person who understood and agreed with the purpose of the clinical trial. The agreement document from the subject or its proxy is required based on the above understanding prior the clinical trial.
(3) Persons who are able to comply with the requirements of the study, receive the medical examination prescribed in the protocol, and report symptoms and other information.

Key exclusion criteria

(1)Persons who are allergic to the test food
(2)Any other person who is judged by the doctor responsible for the trial as in appropriate to participate in the study.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Osamu
Middle name
Last name Katsumi

Organization

Kashiwa Kibou Ophthalmology

Division name

director

Zip code

277-0922

Address

1-6-1-2F, Oshimada, Kashiwa City, Chiba

TEL

04-7157-0818

Email

o.katsumi729@i.softbank.jp


Public contact

Name of contact person

1st name Mamiko
Middle name
Last name Kohno

Organization

Morishita Jintan Co., Ltd.

Division name

Health Care Product Department

Zip code

101-0043

Address

10-2-6F, Kanda Tomiyama-cho, Chiyoda-ku, Tokyo

TEL

03-6206-8138

Homepage URL


Email

m_kohno@jintan.co.jp


Sponsor or person

Institute

Morishita Jintan Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Morishita Jintan Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Social medical corporation sokuinkai kouyou Clinic Clinical Trial Review Committee

Address

3-9 Hiroha-machi, Kitahiroshima City, Hokkaido

Tel

011-372-3900

Email

k-ohno@cli-creative.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

かしわ希望眼科(千葉県)


Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 07 Month 17 Day

Date of IRB

2020 Year 07 Month 31 Day

Anticipated trial start date

2021 Year 09 Month 29 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

On or after November 21, 2020, subject recruitments will be conducted at the facility.


Management information

Registered date

2020 Year 11 Month 19 Day

Last modified on

2021 Year 11 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048516


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name